Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors

被引:34
作者
Peng, Yi-Hui [1 ]
Liao, Fang-Yu [1 ]
Tseng, Chen-Tso [1 ]
Kuppusamy, Ramajayam [1 ]
Li, An-Siou [1 ]
Chen, Chi-Han [1 ]
Fan, Yu-Shiou [1 ]
Wang, Sing-Yi [1 ]
Wu, Mine-Hsine [1 ]
Hsueh, Ching-Cheng [1 ]
Chang, Jia-Yu [1 ]
Lee, Lung-Chun [1 ]
Shih, Chuan [1 ]
Shia, Kak-Shan [1 ]
Yeh, Teng-Kuang [1 ]
Hung, Ming-Shiu [1 ]
Kuo, Ching-Chuan [1 ]
Song, Jen-Shin [1 ]
Wu, Su-Ying [1 ]
Ueng, Shau-Hua [1 ,2 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 35053, Taiwan
[2] Natl Cheng Kung Univ, Sch Pharm, Tainan 70101, Taiwan
关键词
CRYSTAL-STRUCTURES; TRYPTOPHAN; DESIGN; IDO1; INDOLEAMINE-2,3-DIOXYGENASE; DERIVATIVES; REFINEMENT; EXPRESSION; COMPLEXES; MECHANISM;
D O I
10.1021/acs.jmedchem.9b01549
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Indoleamine 2,3-dioxygenase (IDO1) inhibitors are speculated to be useful in cancer immunotherapy, but a phase III clinical trial of the most advanced IDO1 inhibitor, epacadostat, did not meet its primary end point and was abandoned. In previous work, we identified the novel IDOL inhibitor N-(4-chlorophenyl)-2((5-phenylthiazolo[2,3-c][1,2,4]triazol-3-yl)thio)acetamide 1 through high-throughput screening (HTS). Herein, we report a structure activity relationship (SAR) study of this compound, which resulted in the potent IDOL inhibitor 1-(4-cyanophenyl)-3-(3-(cyclopropylethyl)imidazo[2,1-b]thiazol-5-yl)thiourea 47 (hIDO IC50 = 16.4 nM). X-ray cocrystal structural analysis revealed that the basis for this high potency is a unique sulfur aromatic interaction network formed by the thiourea moiety of 47 with F163 and F226. This finding is expected to inspire new approaches toward the discovery of potent IDO1 inhibitors in the future.
引用
收藏
页码:1642 / 1659
页数:18
相关论文
共 50 条
  • [1] Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold
    Brant, Michael G.
    Goodwin-Tindall, Jake
    Stover, Kurt R.
    Stafford, Paul M.
    Wu, Fan
    Meek, Autumn R.
    Schiavini, Paolo
    Wohnig, Stephanie
    Weaver, Donald F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (02): : 131 - 136
  • [2] Research progress of indoleamine 2,3-dioxygenase inhibitors
    Jiang, Tianze
    Sun, Yingying
    Yin, Zhichao
    Feng, Sen
    Sun, Liping
    Li, Zhiyu
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (02) : 185 - 201
  • [3] Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors
    Delfourne, Evelyne
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (10) : 988 - 996
  • [4] N-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase
    Yang, Dan
    Zhang, Shengnan
    Fang, Xin
    Guo, Leilei
    Hu, Nan
    Guo, Zhanling
    Li, Xishuai
    Yang, Shuangshuang
    He, Jin Chao
    Kuang, Chunxiang
    Yang, Qing
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (20) : 9161 - 9174
  • [5] Potent Activation of Indoleamine 2,3-Dioxygenase by Polysulfides
    Nelp, Micah T.
    Zheng, Vincent
    Davis, Katherine M.
    Stiefel, Katherine J. E.
    Groves, John T.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (38) : 15288 - 15300
  • [6] Synthesis of 4-and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase
    Balti, Monaem
    Plas, Aurelie
    Meinguet, Celine
    Haufroid, Marie
    Themans, Quentin
    Efrit, Mohamed Lotfi
    Wouters, Johan
    Lanners, Steve
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3607 - 3610
  • [7] Novel candesartan derivatives as indoleamine 2,3-dioxygenase inhibitors
    Matsuno, Kenji
    Yamazaki, Hiroshi
    Isaka, Yoshinobu
    Takai, Kazushige
    Unno, Yuka
    Ogo, Naohisa
    Ishikawa, Yoshinobu
    Fujii, Satoshi
    Takikawa, Osamu
    Asai, Akira
    MEDCHEMCOMM, 2012, 3 (04) : 475 - 479
  • [8] Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors
    Roehrig, Ute F.
    Awad, Loay
    Grosdidier, Aurelien
    Larrieu, Pierre
    Stroobant, Vincent
    Colau, Didier
    Cerundolo, Vincenzo
    Simpson, Andrew J. G.
    Vogel, Pierre
    Van den Eynde, Benoit J.
    Zoete, Vincent
    Michielin, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1172 - 1189
  • [9] Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase
    Liu, Jiangxin
    Ren, Jian
    Yang, Kun
    Chen, Shuang
    Yang, Xinni
    Zhao, Qin-Shi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235
  • [10] Nitrobenzofurazan derivatives of N′-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1
    Paul, Saurav
    Roy, Ashalata
    Deka, Suman Jyoti
    Panda, Subhankar
    Trivedi, Vishal
    Manna, Debasis
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 : 364 - 375